Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Biomarin Pharmaceutical Inc (BMRN)  
$88.63 1.44 (1.6%) as of 4:30 Fri 4/19


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 188,370,000
Market Cap: 16.70(B)
Last Volume: 1,778,607 Avg Vol: 1,398,026
52 Week Range: $76.22 - $99
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  811
Guru Rank Value     : 0.9
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Kuvan (sapropterin dihydrochloride) for the treatment of phenylketonuria; Naglazyme (galsulfase) the treatment of Mucopolysaccharidosis VI ; Palynziq (pegvaliase-pqpz) for adult patients with phenylketonuria; and Vimizim (elosulfase alpha) for the treatment of Mucopolysaccharidosis IV Type A.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 3,625
Total Buy Value $0 $0 $0 $314,469
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 159,588 261,929 319,053 656,089
Total Sell Value $13,270,852 $22,448,451 $27,661,182 $61,420,002
Total People Sold 5 6 7 7
Total Sell Transactions 10 20 27 56
End Date 2024-03-21 2023-12-19 2023-06-20 2022-06-20

   
Records found: 1303
  Page 46 of 53  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Wood Mark VP, Human Resources   •       –      –    2008-02-21 4 AS $35.93 $109,010 D/D (2,990) 0     -
   Wood Mark VP, Human Resources   •       –      –    2008-02-21 4 OE $6.13 $40,350 D/D 2,990 2,990     -
   Wood Mark VP, Human Resources   •       –      –    2008-01-22 4 AS $35.00 $108,424 D/D (2,990) 0     -
   Wood Mark VP, Human Resources   •       –      –    2008-01-22 4 OE $6.13 $40,337 D/D 2,990 2,990     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2008-01-02 4 AS $35.28 $540,978 D/D (15,000) 7,213     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2008-01-02 4 OE $6.46 $96,900 D/D 15,000 22,213     -
   Swiedler Stuart J SVP, Clinical Affairs   •       –      –    2008-01-02 4 AS $35.28 $451,061 D/D (12,500) 10,000     -
   Swiedler Stuart J SVP, Clinical Affairs   •       –      –    2008-01-02 4 OE $6.13 $76,625 D/D 12,500 22,500     -
   Aselage Steve SVP, Global Commercial Dev   •       –      –    2008-01-02 4 AS $35.28 $180,398 D/D (5,000) 7,034     -
   Aselage Steve SVP, Global Commercial Dev   •       –      –    2008-01-02 4 OE $7.16 $35,800 D/D 5,000 12,034     -
   Wood Mark VP, Human Resources   •       –      –    2007-12-21 4 AS $35.82 $220,474 D/D (6,114) 0     -
   Wood Mark VP, Human Resources   •       –      –    2007-12-21 4 OE $6.13 $94,494 D/D 6,114 6,114     -
   Kakkis Emil D Chief Medical Officer   •       –      –    2007-12-17 4 GD $0.00 $0 D/D 10,000 86,164     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2007-12-17 4 AS $35.15 $532,934 D/D (15,000) 7,213     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2007-12-17 4 OE $6.46 $96,900 D/D 15,000 22,213     -
   Wood Mark VP, Human Resources   •       –      –    2007-11-21 4 AS $25.27 $61,155 D/D (2,365) 0     -
   Wood Mark VP, Human Resources   •       –      –    2007-11-21 4 OE $6.13 $29,517 D/D 2,365 2,365     -
   Kakkis Emil D Chief Medical Officer   •       –      –    2007-10-31 4 B $6.92 $14,101 D/D 2,038 96,164 2.74     -
   Baffi Robert SVP, Technical Operations   •       –      –    2007-10-31 5 B $6.92 $10,766 D/D 1,556 34,680     -
   Davis George Eric VP, General Counsel   •       –      –    2007-10-31 5 B $6.92 $9,617 D/D 1,390 3,997     -
   Cooper Jeffrey H SVP, Chief Financial Officer   •       –      –    2007-10-31 5 B $13.95 $14,019 D/D 1,005 1,005     -
   Aselage Steve SVP, Global Commercial Dev   •       –      –    2007-10-31 4 AB $6.92 $14,800 D/D 2,139 7,034     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2007-10-31 4 AB $6.92 $3,584 D/D 518 7,213     -
   Wood Mark VP, Human Resources   •       –      –    2007-10-24 4 AS $26.00 $21,658 D/D (833) 0     -
   Wood Mark VP, Human Resources   •       –      –    2007-10-24 4 OE $17.54 $14,611 D/D 833 833     -
  1303 Records found
  Previous  40  41  42  43  44  45  46  47  48  49  Next   
  Page 46 of 53
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us